Luminex FLEXMAP 3D bead-based vs. MSD planar multiplex immunoassays for plasma cytokine profiling in brain tumor subjects

In this application note, Luminex compares the performance of two 96-well multiplex immunoassay platforms for assessing plasma cytokine concentrations in people with glioblastoma, melanoma, breast or lung cancer metastases to the brain, and healthy volunteers.